International journal of women's health · 2026
Silent but Destructive: Ureteral Deep Infiltrating Endometriosis Progressing to Renal Injury - A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Asmara Erick Caesarrani, Rachmawati Anita, Nisa Aisyah Shofiatun, Syam Hanom Husni
Аннотация
BACKGROUND: Ureteral endometriosis is a rare form of deep infiltrating endometriosis that may lead to silent ureteral obstruction and progressive renal injury. Early diagnosis remains challenging because symptoms are often nonspecific.
CASE REPORT: A 41-year-old nulliparous woman presented with lower abdominal pain radiating to the rectum and thigh. Pelvic examination revealed an immobile posterior cervical mass. Transvaginal ultrasound demonstrated a deep infiltrating endometriosis nodule associated with hydroureter and grade IV hydronephrosis, which was confirmed by magnetic resonance imaging. Surgical management was recommended; however, the patient declined surgery and opted for conservative treatment. She received monthly leuprolide acetate injections for three months. Follow-up evaluation showed reduction in lesion size and improvement in pain symptoms.
CONCLUSION: Ureteral endometriosis should be considered in reproductive-age women with unexplained hydroureteronephrosis. Hormonal therapy may provide temporary symptom control in patients refusing surgery, although careful follow-up is required because of the risk of ongoing renal damage.
CASE REPORT: A 41-year-old nulliparous woman presented with lower abdominal pain radiating to the rectum and thigh. Pelvic examination revealed an immobile posterior cervical mass. Transvaginal ultrasound demonstrated a deep infiltrating endometriosis nodule associated with hydroureter and grade IV hydronephrosis, which was confirmed by magnetic resonance imaging. Surgical management was recommended; however, the patient declined surgery and opted for conservative treatment. She received monthly leuprolide acetate injections for three months. Follow-up evaluation showed reduction in lesion size and improvement in pain symptoms.
CONCLUSION: Ureteral endometriosis should be considered in reproductive-age women with unexplained hydroureteronephrosis. Hormonal therapy may provide temporary symptom control in patients refusing surgery, although careful follow-up is required because of the risk of ongoing renal damage.